NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...

Our other advanced drug candidate is NV-HHV-1 for the treatment of Shingles. The Company cannot project an exact date for filing an IND for any of its drugs because of dependence on a number of ...

24.8 x 31.8 cm. (9.8 x 12.5 in.) ...

Diwan, Ph.D., the Company's President and Executive Chairman, will be presenting a corporate update at the Spartan Capital Investors Conference on Monday, November 4, 2024 (today) at 9:45 am ... drug ...

47 x 39.5 cm. (18.5 x 15.6 in.) ...

Vietnamese construction giants are expected to continue capitalizing on public investment projects for the remainder of this ...

Black Friday will be with us once again later this month - a time when we'll see prices plummet on a whole pile of CDs and CD ...